Abstract
Patient: Female, 44
Final Diagnosis: Clostridium tertium bacteremia
Symptoms: Fever
Medication: Ertapenem • Metronidazole
Clinical Procedure: —
Specialty: Infectious Disease
Objective:
Unknown etiology
Background:
Clostridium tertium is distributed in the soil and in animal and human gastrointestinal tracts. C. tertium has been isolated from patients with blood diseases, immune disorders, and abdominal surgeries. Glyphosate is toxic, causing cause eye and skin irritation, gastrointestinal pain, and vomiting. Ingestion of herbicides modifies the gastrointestinal environment, which stresses the living organisms. However, there has been little attention to cases of bacteremia in patients recovering from suicide attempt by ingesting herbicide.
Case Report:
Clostridium tertium was identified in a 44-year-old female who attempted suicide by glyphosate (a herbicide) ingestion. The 16S rRNA sequences from all colonies were 99% identical with that of C. tertium (AB618789) found on a BLAST search of the NCBI database. The bacterium was cultured on TSA under aerobic and anaerobic conditions. Antimicrobial susceptibility tests performed under both aerobic and anaerobic conditions showed that the bacterium was susceptible to penicillin, a combination of β-lactamase inhibitor and piperacillin or amoxicillin, and first- and second- generation cephalosporins. However, it was resistant to third- and fourth-generation cephalosporins.
Conclusions:
Glyphosate herbicide might be a predisposing factor responsible for the pathogenesis of C. tertium. The results highlight the need for careful diagnosis and selection of antibiotics in the treatment of this organism.
MeSH eywords: Bacteremia, Clostridium tertium, Herbicides
Background
Clostridium tertium is an aerotolerant gram-positive bacillus that is capable forming spores under anaerobic conditions for its growth. The bacterium is widely distributed in the soil [1] and in animal and human gastrointestinal tracts [2–5]. It is a non-toxin-producing bacterium and is regarded to be a lowvirulence pathogen, in contrast to C. perfringens. In fact, infection with this pathogen has been rare in humans after being first described in 1917 [6]. However, there have been human cases of C. tertium infection reported in last 2 decades. C. tertium has been isolated from patients with blood diseases such as leukemia, hepatic failure, and immune disorders. There are some reports of C. tertium infection in patients experiencing abdominal surgeries such as gastrostomy.
There have been few reports of bacteremia in patients recovered from suicide attempt by ingesting herbicides. Glyphosate (N-(phosphonomethyl) glycine) is a highly effective herbicide because of its potent and specific inhibition of 5-enolpyruvyl shikimate 3-phosphate synthase and enzyme of the shikimate pathway, which governs the synthesis of aromatic amino compounds in higher plants, algae, bacteria, and fungi [7]. Glyphosate-containing products are acutely toxic to humans. Various microorganisms have different sensitivities to glyphosate [8–10]. Herbicides modify the environment, which stresses living organisms [11,12]. Herein, we report a case of bacteremia due to C. tertium from a patient who had recovered from a suicide attempt by glyphosate ingestion. In addition, C. tertium infection might be involved in acute bronchopneumonia.
Case Report
A 44-year-old woman attempted suicide by glyphosate (herbicide) ingestion on May 15, 2012 and was admitted to Chonbuk National University Hospital. The amount of glyphosate ingested was about 20 ml. Twelve days after the suicide attempt, the patient presented with a high fever and general myalgia. Due to her symptoms, she visited the emergency room. At that time, her blood pressure was 80/60 mmHg, pulse was 70/min, respiration rate was 18/min, and temperature was 38.0°C. Laboratory studies revealed a white blood cell (WBC) count of 2010/ml, hemoglobin level of 14.2 g/dl, platelet count of 80 000/ml, serum creatinine of 3.59 mg/dl, aspartate aminotransferase level of 2428 IU/l, alanine amino transferase level of 1213 IU/l, total bilirubin level of 0.30 mg/dl, hs-CRP level of 20.77 mg/l, and PCT level of 1.08 ng/ml. Urine analysis revealed pyuria (WBC count >30/HPF). In addition, high-resolution computed tomography (CT) of the chest revealed acute bronchopneumonia in the left lower lobe. The initial antibiotic therapy included cefepime and azithromycin for 8 days. However, fever persisted, hs-CRP level increased abruptly to 107.49 mg/l, and PCT level increased to 3.53 ng/ml during antibiotic treatment. C. tertium was isolated from initial blood samples from a central catheter. Antibiotics were changed to ertapenem and metronidazole. After 16 days of appropriate antibiotic therapy, her clinical symptoms and signs completely disappeared and she was discharged.
In the initial blood culture, we observed slender Gram-positive rods under aerobic conditions, identified as Lactobacillus sp. by using the Vitek2 identification system (BioMérieux Inc., Hazelwood, USA). The blood culture was subcultured, resulting in a pure colony on tryptic soy agar (Sigma Aldrich, St. Louis, USA) under aerobic conditions. The randomly selected colonies were separately cultured in TSB (Sigma Aldrich, St. Louis, USA) for bacterial DNA extraction, followed by identification using 16S rRNA sequencing. The resultant colonies were submitted for spore staining according to the Schaseffer-Fulton method using malachite green (Life Technologies, Grand Island, USA). The 16S rRNA sequences from all colonies showed 99% identity with that of C. tertium (AB618789) on BLAST searching of the NCBI database. The bacterium was carefully cultured on TSA under aerobic and anaerobic conditions The 16S rRNA sequences from all colonies showed 99% identity with that of C. tertium (AB618789) on BLAST searching of NCBI database. The bacterium was separately cultured on TSA under aerobic and anaerobic conditions.
Under aerobic condition, morphology and staining of the bacterium were similar with that from initial blood culture (Figure 1A). Under anaerobic conditions, the bacterium showed a tennis racquet-like shape with terminally located ova with blue color, indicating spore formation (Figure 1B). Antibiotic susceptibility tests for the bacterium were also performed under aerobic and anaerobic conditions. Although there were differences in susceptibilities to most antibiotics between both conditions, there is no difference in susceptibilities of C. tertium strain to antibiotics on interpretation based on clear zone diameter. Under both aerobic and anaerobic conditions, C. tertium was sensitive to penicillin, piperacillin/tazobactam, Amoxicillin/clavulanic acid, Cephalothin, Cefoxitin, Imipenem, Moxifloxacin, Vancomycin, Tetracycline, Rifampicin, and Sulfamethoxazole/Trimethoprim but resistance to Ceftiofur, Cefotaxime, Ceftazidime, Cefepime, Amikacin, Gentamicin, Clindamycin, and Metronidazole (Table 1).
Figure 1.

Spore stain of Clostridium tertium on two different cultivations, aerobic (A) and anaerobic (B) conditions.
Table 1.
Antibiotic resistance of Clostridium tertium under anaerobic and aerobic cultivations.
| Antibiotics | Potency | Anaerobic | Aerobic | ||
|---|---|---|---|---|---|
| Clear zone | Interpretation | Clear zone | Interpretation | ||
| Penicillin | 10 IU | 23.5 mm | S | 22.5 mm | S |
| Piperacillin/tazobactam | 110 ug | 22.5 mm | S | 28.5 mm | S |
| Amoxicillin/clavulanic acid | 30 ug | 40 mm | S | 37 mm | S |
| Cephalothin | 30 ug | 22 mm | S | 25 mm | S |
| Cefoxitin | 30 ug | 28 mm | S | 32 mm | S |
| Imipenem | 10 ug | 35 mm | S | 40 mm | S |
| Moxifloxacin | 5 ug | 24 mm | S | 28 mm | S |
| Vancomycin | 30 ug | 27 mm | S | 28 mm | S |
| Tetracycline | 30 ug | 39 mm | S | 34 mm | S |
| Rifampicin | 5 ug | 26 mm | S | 28 mm | S |
| Sulfamethoxazole/Trimethoprim | 25 ug | 36 mm | S | 36 mm | S |
| Ceftiofur | 30 ug | 12.5 mm | R | 10 mm | R |
| Cefotaxime | 30 ug | 0 mm | R | 0 mm | R |
| Ceftazidime | 30 ug | 0 mm | R | 0 mm | R |
| Cefepime | 30 ug | 0 mm | R | 0 mm | R |
| Amikacin | 30 ug | 11 mm | R | 15.5 mm | R |
| Gentamicin | 5 ug | 11 mm | R | 16.5 mm | R |
| Clindamycin | 2 ug | 10 mm | R | 10 mm | R |
| Metronidazole | 5 ug | 0 mm | R | 0 mm | R |
S – susceptible, R – resistant, mm; millimeter.
Discussion
We presented a case report of bacteremia and acute bronchopneumonia due to C. tertium in a patient recovering from deliberate ingestion of glyphosate herbicide. C. tertium was considered as the pathogen [2,13,14]. C. tertium isolates are usually found with other bacteria [3,13,15,16] and sometimes it is the only isolate [15,17]. Patients who died and who had C. tertium in their blood cultures had severe underlying diseases [13,18] that were potentially fatal in the short term. As a result, the bacterium’s virulence has not yet been clearly determined [3]. The present C. tertium was misidentified as Lactobacillus sp. by using Vitek2 identification on initial blood culture under aerobic conditions. There are many reports of misidentification of C. tertium under aerobic conditions. C. tertium could be mistaken for a Gram-negative enteric organism because of its various degree of Gram straining. In addition, the bacterium is an aero-tolerant species [19]. It could share similar biochemical characteristics with Bacillus sp., Lactobacillus sp., and Corynebacterium sp. under aerobic growth. When identified as Lactobacillus species by phenotypic methods, clinicians should be aware of the possibility of aero-tolerant Clostridium sp. and perform additional testing to rule out these organisms. C. tertium can be differentiated from other bacteria by many methods; for example, catalase and oxidase testing, anaerobically spore-formation, and gas chromatography profiling. In our case, we correctively identified C. tertium by the presence of spores under anaerobic growth and 16S rRNA sequencing from misidentification of the present strain using the Vitek2 system.
Two or 3 antibiotics have generally been used for controlling C. tertium in humans. However, there is no guideline for treatment to C. tertium infection. Based on antimicrobial susceptibility tests for C. tertium strains from the literature, there are differences among clinical C. tertium strains. Some previous studies showed resistance of C. tertium to β-lactams, clindamycin, and metronidazole. There is limited information about resistance of C. tertium in patients with bacteremia and pneumonia after glyphosate ingestion. There was a case of bacteremia reported due to Bacillus licheniformis from a convalescent patient after a suicide attempt [20].
Although there are many cases of C. tertium infection in humans, to the best of our knowledge, this report is the first from Korea. Most patients had various abdominal disorders associated with intestinal mucosa damage, a prerequisite providing a portal for entry for C. tertium from the gut. Intestinal pathology can therefore be considered the major risk factor for development of C. tertium bacteremia. In the previous cases and/or retrospective studies, intestinal mucosa damage has been suggested to be one of the major risk factors for bacteremia due to C. tertium [13].
In agreement with the previous studies, the bacteremia might be due to translocation of C. tertium from the gastrointestinal tract by intestinal mucosa damage from herbicide toxicity combined with excessive stress. The patient recovered from bacteremia and pneumonia and was discharged after 16 days of appropriate antibiotic therapy using ertapenem and metronidazole.
One study reported 2 cases, of which 1 patient was being treated for a first relapse of acute myeloblastic leukemia, and the second was receiving high-dose chemotherapy with hematopoietic stem cell support for non-Hodgkin lymphoma. The first patient was completely asymptomatic, whereas the other case improved clinically and bacteriologically despite in vitro evidence of inadequate antibiotic therapy [21]. However, they were reported as true pathogens in both cases because the patients were at risk (hematologic malignancies, leukopenia, and chemotherapy) for C. tertium bacteremia. Leukopenia is a known as risk factor for C. tertium bacteremia, as shown in the present case.
Conclusions
This report was limited because we did not perform blood or urine tests to detect glyphosate. It is not clear if the detected C. tertium was a contaminant or a true pathogen. However, the patient had a definite risk factor for C. tertium bacteremia as a complication of glyphosate ingestion. Ingestion of glyphosate might be a pre-disposing factor for the pathogenesis of C. tertium bacteremia.
References:
- 1.Kataoka N, Tokiwa Y. Isolation and characterization of an active mannanase-producing anaerobic bacterium, Clostridium tertium KT-5A, from lotus soil. J App Microbiol. 1998;84:357–67. doi: 10.1046/j.1365-2672.1998.00349.x. [DOI] [PubMed] [Google Scholar]
- 2.Gosbell IB, Johnson CG, Newton PJ, Jelfs J. Clostridium tertium bacteremia: 2 cases and review. Pathology. 1996;28:70–73. doi: 10.1080/00313029600169573. [DOI] [PubMed] [Google Scholar]
- 3.Ray P, Das A, Singh K, et al. Clostridium tertium in necrotizing fasciitis and gangrene. Emerg Infect Dis. 2003;9:1347–48. doi: 10.3201/eid0910.030287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Severin A, Remi P, Berth A, et al. [Acute pancreatitis complicated by Clostridium tertium septicaemia] Presse Med. 2005;34:446–47. doi: 10.1016/s0755-4982(05)83941-7. [in French] [DOI] [PubMed] [Google Scholar]
- 5.Valtonen M, Sivonen A, Elonen E. A cluster of seven cases of Clostridium tertium septicemia in neutropenic patients. Eur J Clin Microbiol Infec Dis. 1990;9:40–42. doi: 10.1007/BF01969532. [DOI] [PubMed] [Google Scholar]
- 6.Thaler M, Gill V, Pizzo PA. Emergence of Clostridium tertium as a pathogen in neutropenic patients. Am J Med. 1986;81:596–600. doi: 10.1016/0002-9343(86)90543-7. [DOI] [PubMed] [Google Scholar]
- 7.Barry G. World Patent. PS: Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases. 1992 WO 92/04449.
- 8.Bonnet JL, Bonnemoy F, Dusser M, Bohatier J. Assessment of the potential toxicity of herbicides and their degradation products to nontarget cells using two microorganisms, the bacteria Vibrio fischeri and the ciliate Tetrahymena pyriformis. Environ Toxicol. 2007;22:78–91. doi: 10.1002/tox.20237. [DOI] [PubMed] [Google Scholar]
- 9.Clair E, Linn L, Travert C, et al. Effects of Roundup((R)) and glyphosate on three food microorganisms: Geotrichum candidum, Lactococcus lactis subsp. cremoris and Lactobacillus delbrueckii subsp. bulgaricus. Curr Microbiol. 2012;64:486–91. doi: 10.1007/s00284-012-0098-3. [DOI] [PubMed] [Google Scholar]
- 10.Hernando MD, De Vettori S, Martinez Bueno MJ, Fernandez-Alba AR. Toxicity evaluation with Vibrio fischeri test of organic chemicals used in aquaculture. Chemosphere. 2007;68:724–30. doi: 10.1016/j.chemosphere.2006.12.097. [DOI] [PubMed] [Google Scholar]
- 11.Missous G, Thammavongs B, Dieuleveux V, et al. Improvement of the cryo-preservation of the fungal starter Geotrichum candidum by artificial nucleation and temperature downshift control. Cryobiology. 2007;55:66–71. doi: 10.1016/j.cryobiol.2007.05.004. [DOI] [PubMed] [Google Scholar]
- 12.Thammavongs B, Denou E, Missous G, et al. Response to environmental stress as a global phenomenon in biology: The example of microorganisms. Microbes Environ. 2008;23:20–23. doi: 10.1264/jsme2.23.20. [DOI] [PubMed] [Google Scholar]
- 13.Miller DL, Brazer S, Murdoch D, et al. Significance of Clostridium tertium bacteremia in neutropenic and nonneutropenic patients: review of 32 cases. Clin Infect Dis. 2001;32:975–78. doi: 10.1086/319346. [DOI] [PubMed] [Google Scholar]
- 14.Tappe D, Dirks J, Muller R, et al. Fatal Clostridium tertium septicemia in a nonneutropenic patient. J Infect. 2005;50:76–80. doi: 10.1016/j.jinf.2004.04.005. [DOI] [PubMed] [Google Scholar]
- 15.Speirs G, Warren RE, Rampling A. Clostridium tertium septicemia in patients with neutropenia. J Infec Dis. 1988;158:1336–40. doi: 10.1093/infdis/158.6.1336. [DOI] [PubMed] [Google Scholar]
- 16.Steyaert S, Peleman R, Vaneechoutte M, et al. Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins. J Clinic Microbiol. 1999;37:3778–79. doi: 10.1128/jcm.37.11.3778-3779.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rampling A, Speirs G, Warren RE. Clostridium tertium and the gut. Lancet. 1988;1:534. doi: 10.1016/s0140-6736(88)91329-3. [DOI] [PubMed] [Google Scholar]
- 18.Leegaard TM, Sandven P, Gaustad P. Clostridium tertium: 3 case reports. Scandinavian J Infec Dis. 2005;37:230–32. doi: 10.1080/00365540410020910. [DOI] [PubMed] [Google Scholar]
- 19.Henry H. An investigation of the cultural reactions of certain anaerobes found in wounds. J Pathol Bacteriol. 1917;21:344–85. [Google Scholar]
- 20.Hannah WN, Jr, Ender PT. Persistent Bacillus licheniformis bacteremia associated with an international injection of organic drain cleaner. Clin infec Dis. 1999;29:659–61. doi: 10.1086/598647. [DOI] [PubMed] [Google Scholar]
- 21.Vanderhofstadt M, Andrev M, Lonchay C, et al. Clostridium tertium bacterimia: contamination or true pathogen? A report of two cases and review of the literature. Int J Infect Dis. 2010. pp. e335–e337. [DOI] [PMC free article] [PubMed]
